Iris Uniroma1 Prodmetadata only
Real‐World Efficacy Profile of Compassionate Use of Asciminib in an Italian, Multi‐Resistant Chronic‐Phase Chronic Myeloid Leukemia (CML‐CP) Patient Population
tki resistance/intolerance, asciminib, chronic myeloid leukemia in chronic phase (cml‐cp), major molecular response (mmr), real‐world, tyrosine kinase inhibitor (tki)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 239279
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.